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Acquiring the gene expression proﬁles of speciﬁc neuronal cell-types is important for
understanding their molecular identities. Genome-wide gene expression proﬁles of
genetically deﬁned cell-types can be acquired by collecting and sequencing mRNA that
is bound to epitope-tagged ribosomes (TRAP; translating ribosome afﬁnity puriﬁcation).
Here, we introduce a transgenic mouse model that combines theTRAP technique with the
tetracycline transactivator (tTA) system by expressing EGFP-tagged ribosomal protein L10a
(EGFP-L10a) under control of the tetracycline response element (tetO-TRAP). This allows
both spatial control of EGFP-L10a expression through cell-type speciﬁc tTA expression, as
well as temporal regulation by inhibiting transgene expression through the administration
of doxycycline. We show that crossing tetO-TRAP mice with transgenic mice expressing
tTA under the Camk2a promoter (Camk2a-tTA) results in offspring with cell-type speciﬁc
expression of EGFP-L10a in CA1 pyramidal neurons and medium spiny neurons in the
striatum. Co-immunoprecipitation conﬁrmed that EGFP-L10a integrates into a functional
ribosomal complex. In addition, collection of ribosome-boundmRNA from the hippocampus
yielded the expected enrichment of genes expressed in CA1 pyramidal neurons, as well
as a depletion of genes expressed in other hippocampal cell-types. Finally, we show
that crossing tetO-TRAP mice with transgenic Fos-tTA mice enables the expression of
EGFP-L10a in CA1 pyramidal neurons that are activated during a fear conditioning trial. The
tetO-TRAP mouse can be combined with other tTA mouse lines to enable gene expression
proﬁling of a variety of different cell-types.
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INTRODUCTION
Acquiring the gene expression proﬁles of individual cell-types is
imperative for understanding their molecular identities. Although
traditionally cell types are deﬁned by their morphology and
functional properties, recent studies have shown that many sub-
classes of neurons can also be distinguished through genome-wide
gene expression proﬁling (Okaty et al., 2011). These studies used
various techniques to collect mRNA from deﬁned groups of
neurons, including laser capture microdissection (LCM) and
ﬂuorescence-activated cell sorting (FACS). However, both LCM
and FACS-based methods have various drawbacks. LCM often
results in low levels of mRNA, and is prone to contamination from
the close proximity of off-target cell-types (Okaty et al., 2011). In
addition, LCM requires ﬁxation of the tissue which alone can
increase degradation of nucleic acids. Use of manual cell dissoci-
ation techniques can eliminate the off-target contamination seen
with LCM. However, this technique can be very time consuming
as large numbers of cells must be isolated in order to collect sufﬁ-
cientmRNA quantities. FACS greatly increases the number of cells
that can be isolated. However, the harsh conditions of the dissocia-
tion and sorting process causes neurons to lose their processes and
increases the risk of introducing gene expression artifacts (Okaty
et al., 2011).
Many of the technical limitations of traditional mRNA collec-
tion methods can be circumvented with the translating ribosome
afﬁnity puriﬁcation (TRAP) technique (Doyle et al., 2008; Heiman
et al., 2008, 2014), and other methods based on collecting epitope-
tagged ribosomes (Sanz et al., 2009). The TRAP technique utilizes
transgenically expressed EGFP-L10a (enhanced green ﬂuores-
cent protein fused with the ribosomal protein L10a) to afﬁnity
purify EGFP-tagged ribosomes fromgenetically deﬁned cell-types.
Through analysis of the co-puriﬁedmRNA, it is possible to acquire
the translational proﬁle of the cell-type in which EGFP-L10a
was expressed. TRAP has been applied to cell-types in various
mouse tissues including brain (Doyle et al., 2008; Heiman et al.,
2008; Schmidt et al., 2012; Ainsley et al., 2014), heart (Fang et al.,
2013; Zhou et al., 2013), liver (Wilkins et al., 2014), and kidney
(Liu et al., 2014). In addition to mice, TRAP has been applied
in other species such as drosophila and zebraﬁsh (Thomas et al.,
2012; Huang et al., 2013; Tryon et al., 2013). TRAP has the advan-
tages of beingmore high-throughput than LCMwithout requiring
the dissociation of neurons from intact tissue as needed for
FACS. In addition, the ribosome-bound mRNA collected through
TRAP provides a more accurate representation of cellular protein
content than the total mRNA collected through LCM or FACS
(Schwanhausser et al., 2011).
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Here, we introduce a novel, versatile transgenic mouse model
for the spatial and temporal control of EGFP-L10a expression,
thereby increasing the number of cell-types amendable to TRAP
analysis. We achieved this by placing expression of EGFP-L10a
under control of the tetOpromoter. The tetOpromoter is activated
by tetracycline transactivator (tTA), which can be temporally sup-
pressed through addition of doxycycline (dox) to the food of the
mice (Gossen and Bujard, 1992). As a result, temporally controlled
cell-type speciﬁc gene expression can be achieved by breeding tetO
mouse lines with mouse lines that express tTA under cell-type
speciﬁc promoters. Accordingly, the tTA system has been used
in a wide variety of studies that required spatial and temporal
control of transgene expression (Schonig et al., 2010), including
studies on the neural correlates of memory storage (Mayford
et al., 1996; Reijmers et al., 2007). Here we crossed the tetO-
TRAP mouse with both Camk2a-tTA and Fos-tTA driver mice,
thereby generating Camk2a-TRAP and Fos-TRAP mice, respec-
tively. In a recent study we used the Camk2a-TRAP mouse to
collect ribosome-bound mRNA from dendrites of CA1 pyramidal
neurons (Ainsley et al., 2014). Here we present a more exten-
sive characterization of the EGFP-L10a expression patterns in the
Camk2a-TRAP mouse, and demonstrate how it can be used to
collect ribosome-boundmRNA from complete hippocampal CA1
neurons. In addition, we demonstrate with the Fos-TRAP mouse
how the temporal control conferred by the tTA system enables the
expression of EGFP-L10a in neurons activated during a deﬁned
time-window.
MATERIALS AND METHODS
TRANSGENIC ANIMAL CREATION AND BREEDING
All animal procedures were performed in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Tufts University
Institutional Animal Care and Use Committee. We generated a
transgenic mouse expressing the ribosomal protein L10a tagged
with EGFP under the control of the tetracycline operon (tetO-
TRAP). The EGFP-L10a fusion protein coding sequence in a
pLD53.SC.EGFP-L10a plasmid was donated by Nathaniel Heintz
at Rockefeller University. The plasmid was transformed into
One Shot PIR1 Chemically Competent E. coli (Life Technologies
#C1010-10) and the EGFP-L10a sequence was obtained and ver-
iﬁed using the services of the Tufts University Core Facility. A
DNA fragment containing the EGFP-L10a coding sequence was
removed by incubating the plasmid with AfeI and BamHI restric-
tion endonucleases. After agarose gel electrophoresis, a ∼1.4 kb
band containing the EGFP-L10a coding sequence was cut from
the gel and puriﬁed using the PureLink Quick Gel Extraction Kit
(Life Technologies #K2100-12). This fragment was treated with T4
DNA Polymerase (NEB #M0203S) to form blunt ends. The blunt
end EGFP-L10a fragment was cloned into pMM400Sﬁ, a plasmid
for transgenicmouse creation containing a tet operon (donated by
Mark Mayford at the Scripps Research Institute). pMM400Sﬁ was
digested with the EcoRV restriction endonuclease to create blunt
ends and then treated with Calf Intestinal Alkaline Phosphatase
(Life Technologies #18009-019) to dephosphorylate the blunt ends
and prevent self-ligation. The blunt end EGFP-L10a fragment was
cloned into linearized pMM400Sﬁ by incubating with T4 DNA
Ligase (NEB, #M0202S) overnight at 16◦C. The correct sequence
and insert orientation was veriﬁed by DNA sequencing.
Pronuclear microinjection of pMM400Sﬁ.EGFP-L10a into
C57BL/6J embryos was performed at the Tufts Medical Cen-
ter Transgenic Core Facility. Potential transgenic founder lines
were screened for transgene integration using the following
genotyping primers: (5′-CAGAACGCACACCGAGAACT-3′, 5′-
CTTCAAGGACGACGGCAACT-3′). Founders with detectable
transgene integration were crossed with C57BL/6J mice to
ensure heritability. Offspring carrying the transgene were
crossed to Camk2a-tTA transgenic mice (JAX Stock Num-
ber 003010) to induce transgene expression in Camk2a-
positive neurons in the forebrain. Individual founder lines
were screened for strong, speciﬁc expression matching the
expected spatial pattern and one line was used for all fur-
ther experiments. This tetO-TRAP transgenic mouse has
been submitted to the Jackson Laboratory for distribution
(JAX Stock Number 024898).
FEAR CONDITIONING
To ensure that mice remained in a resting state with minimal neu-
ronal activation prior to fear conditioning (FC), all animals were
singly housed and left undisturbed for at least 3 days prior to the
start of FC. This enabled us to control neuronal activation with
high temporal speciﬁcity.
Camk2a-TRAP mice (Figure 3 )
Male and female, 2–3 month old mice were singly housed for
at least 3 days prior to behavioral testing. On day 0, mice were
submitted to one contextual FC trial. FC trials were performed
in a specialized chamber (Coulbourn Instruments; H10-11RTC,
120W × 100D × 120H) and consisted of 500 s with 2 s long,
0.7 mA foot shocks administered at 198, 278, 358, and 438 s.
Fos-TRAP mice (Figure 5 )
Male and female, 3–4 month mice were singly housed for at least
5 days prior to behavioral testing. On day-3, dox was removed
from the food. On day 0, mice were then either left in their cage
until tissue dissection (home cage, HC), or submitted to three
contextual FC trails each spaced three hours apart. At the end of
the third FC trial, all Fos-TRAP mice (HC and FC) were returned
to a diet containing dox.
TISSUE PREPARATION FOR IMMUNOHISTOCHEMISTRY AND IMAGE
COLLECTION
Immediately following behavioral testing (Camk2a-TRAP mice),
or onday 3 after FC (Fos-TRAPmice),micewere anesthetizedwith
ketamine/xylazine and transcardially perfused with 0.1 M phos-
phate buffer followed by 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer. Brains were removed and post-ﬁxed in 4% PFA
for 24 h. Brains were transferred to 30% sucrose for 48–72 hours,
then snap frozen in isopentane. Coronal brain sections were sliced
at 20 μm using a cryostat. Sections were stored at −20◦C in
cryoprotectant until use. Brain sections were washed in a solu-
tion of phosphate buffered saline (PBS) with 0.25% Triton-X-100
(PBS-T). Sections were then blocked at room temperature for 1 h
in PBS-T containing 10% normal goat serum. Primary antibod-
ies (Aves chicken anti-GFP 1:500, Millipore mouse anti-gad67
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(Gad1) 1:10,000, Abcam rabbit anti-Gfap 1:2,000) were diluted
in blocking solution and incubated overnight at 4◦C. Speciﬁcity
of all three primary antibodies was supported by the following
three observations: (1) the staining patterns matched the known
subcellular localization of the three proteins (extranuclear soma
and processes), (2) morphology of the labeled cells, and (3)
location of the labeled cells. After extensive washes with PBS-T,
secondary antibodies (All from Jackson Immuno research; goat
anti-chicken DyLight 488 1:500, goat anti-mouse cy3 1:2000, goat
anti-rabbit DyLight 649 1:500) were diluted in blocking solu-
tion and applied to the sections for 2 h at room temperature
followed by extensive PBS washes. Sections were stained with
DAPI to visualize nuclei, mounted onto slides, coverslipped, and
stored at 4◦C. For Figures 2D–G and 5 a confocal laser-scanning
microscope was used for image acquisition (Nikon-A1R). For
Figures 1C and 2A–C a slide scanner was used (Zeiss Axio Imager
Z2 epiﬂuorescence microscope with a Maerzhaeuser motorized
scanning stage). For Figure 4 a brightﬁeld microscope was used
(Nikon E800).
IMMUNOPRECIPITATION AND mRNA ISOLATION
RNA was isolated using a modiﬁed version of the TRAP tech-
nique (Doyle et al., 2008; Heiman et al., 2008) that was optimized
to remove background (Ainsley et al., 2014). Brieﬂy, an anti-
GFP antibody (HtzGFP-19C8) from the Monoclonal Antibody
Core Facility at the Memorial Sloan-Kettering Cancer Center was
covalently bound to magnetic epoxy beads (Invitrogen) followed
by BSA treatment to reduce non-speciﬁc binding. Immediately
following behavioral testing, Camk2a-TRAP mice were anes-
thetized using isoﬂurane. The hippocampi were rapidly dissected
and rinsed in ice-cold dissection buffer (Heiman et al., 2008).
Each hippocampus was added to 150 μl of homogenization
buffer (Heiman et al., 2008) and homogenized using an automatic
pestle. The tissue was centrifuged at 15,000 RPM for 10 min
at 4◦C. The lysate was transferred to a clean tube. For each
sample, 1000 μg of protein was added to the prepared beads.
Samples were incubated with the beads for 1 h at 4◦C. The
supernatant (SN) was saved for comparison to the immunopre-
cipitate (IP). After ﬁve washes with a KCl buffer (Heiman et al.,
2008), RNA was extracted with Trizol LS. A back extraction was
used to improve yield. Organic contaminants were removed with
butanol and water-saturated diethyl ether washes (Krebs et al.,
2009). RNA was precipitated using NaOAc, isopropanol, and
linear acrylamide overnight at −80◦C. After two washes with
80% EtOH, the RNA was resuspended in 15 μl nuclease-free
water.
CO-IMMUNOPRECIPITATION AND WESTERN BLOT
Protein immunoprecipitations were performed as described above
for mRNA isolation. Before the start of the IP, 2.5% of the sam-
ple was removed and used as the input control. After the KCL
buffer washes, the beads were saturated with sample buffer con-
taining a reducing agent (Invitrogen). Samples were fractionated
by gel electrophoresis using 4−12% Bis-Tris gels (Invitrogen),
and transferred to nitrocellulose membranes (Invitrogen iBlot
system). Membranes were blocked in 5% non-fat dried milk
(NFDM) in TBST for 1 h and incubated in primary antibody
FIGURE 1 | Generation of a tetO driven EGFP-L10a transgenic mouse.
(A) Construct used to create the tetO-TRAP mouse line. (B) Model of the
Camk2a-TRAP mouse. Camk2a-tTA mice were bred with tetO-TRAP mice
to create Camk2a-TRAP mice. Expression of tTA under control of the
Camk2a promoter leads to activation of the tetracycline response element
(tetO) to drive expression of EGFP-L10a only in cells expressing Camk2a.
(C) EGFP-L10a expression throughout the brain of a 3 month old
Camk2a-TRAP mouse kept on food without doxycycline (dox) throughout
life. Green, EGFP-L10a; red, Gad1; blue, dapi. Scale bar, 2 mm.
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FIGURE 2 | EGFP-L10a expression in the Camk2a-TRAP mouse line.
(A) EGFP-L10a is highly expressed in pyramidal neurons of the CA1 region
of the hippocampus. No EGFP-L10a is seen in the CA3 or dentate gyrus.
Scale bar, 0.5 mm. (B) EGFP-L10a expression in medium spiny neurons of
the striatum. Scale bar, 0.5 mm. (C) EGFP-L10a is sparsely expressed in
projection neurons of the basal amygdala. Scale bar 0.5 mm. (D–G)
EGFP-L10a is expressed exclusively in Camk2a expressing pyramidal
neurons of the CA1 region of the hippocampus. No overlap of EGFP-L10a
was observed with the interneuron marker Gad1, marked by ﬁlled in
arrows (E), or the astrocyte marker Gfap, marked by the opened arrow
(F). (D) EGFP-L10a, (E) Gad1, (F) Gfap, (G) Merge (including DAPI, blue).
(D–G) scale bars, 10 μm.
diluted in 2% NFDM overnight at 4◦C (HtzGFP-19C8 from
the Monoclonal Antibody Core Facility at the Memorial Sloan-
Kettering Cancer Center 1:500, Cell Signaling goat anti-mouse
RPS6 1:1000, Millipore goat anti-mouse gapdh 1:20,000). The
following day, membranes were washed in TBST and probed
with secondary antibody for 1 h at room temperature (All from
Jackson Immuno Research; donkey anti-mouse HRP, donkey
anti-rabbit HRP). Immunoblots were visualized using Western
Lighting® Plus-ECL (PerkinElmer) according to manufacturer’s
instructions.
QUANTITATIVE RT-PCR AND BIOANALYZER ANALYSIS
All mRNA samples were DNase treated to remove any genomic
DNA contamination by treatment for 30 min with TURBOTM
DNase (Ambion). The DNase was inactivated using a phenol–
chloroformextraction. cDNA librarieswere preparedusing reverse
transcription (RT) with Superscript III (Invitrogen) according
to the manufacturer’s instructions, with the exception that both
random hexamers and anchored-oligo dT primers were used
during the RT reaction. Quantitative RT-PCR was performed
with SYBR Green PCR master mix (Applied Biosystems) on the
Mx4000 thermo cycler (Agilent) using the primer sequences listed
in Table 1. The ct (ct = ct1 – ct2) was calculated
from three biological replicates per primer set where ct1 rep-
resented the normalized SN value to β-actin (ct1 = gene SN
ct – β-actin SN ct), and ct2 represented the normalized IP
value to β-actin (ct2 = gene IP ct – β-actin IP ct). Bioana-
lyzer analysis was performed using the Agilent Technologies 2100
Bioanalyzer with RNA pico chips according to the manufacturers’
instructions.
RESULTS
GENERATION OF A MOUSE LINE THAT EXPRESSES EGFP-L10a UNDER
CONTROL OF THE tetO PROMOTER
We generated a transgenic mouse expressing the ribosomal pro-
tein L10a tagged with EGFP under the control of the tetracycline
operon (tetO-TRAP; Figure 1A, seeMaterials andMethods). After
screening multiple founder lines, one line was selected for fur-
ther use. To test the ability of our tetO-TRAP mouse line to
express EGFP-L10a in a tTA-dependent manner, we crossed the
tetO-TRAP mouse with a Camk2a-tTA mouse to create a mouse
that expresses EGFP-L10a under the Camk2a promoter (Camk2a-
TRAP; Figure 1B). Previous work using the same Camk2a-tTA
drive line resulted in strong transgene expression in the CA1
region of the hippocampus (but not CA3 or dentate gyrus)
as well as strong expression throughout the striatum (Mayford
et al., 1996). Immunohistochemical analysis of brain sections
from 3 month old Camk2a-TRAP mice revealed a similar expres-
sion pattern (Figure 1C). The CA1 region of the hippocampus
showed strong expression of EGFP-L10a, while the CA3 and
dentate gyrus did not express EGFP-L10a (Figure 2A). Strong
EGFP-L10a expression was also observed in the striatum, and
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Table 1 | Primer sequences used for quantitative RT-PCR.
Gene name Primer sequence
Gad1_F 5′-CACAGGTCACCCTCGATTTTT-3′
Gad1_R 5′-ACCATCCAACGATCTCTCTCATC-3′
Pkia_F 5′-TCGCAGCCACGGGTGAAACG-3′
Pkia_R 5′-TCCAAGCACAGCCCAGGTGA-3′
Gfap_F 5′-CGGAGACGCATCACCTCTG-3′
Gfap_R 5′-AGGGAGTGGAGGAGTCATTCG-3′
Camk2a_F 5′-TTTGAGGAACTGGGAAAGGG-3′
Camk2a_R 5′-CATGGAGTCGGACGATATTGG-3′
Naa38_F 5′-GGCTGTTATTACTTCTGATGGCA-3′
Naa38_R 5′-ACACCACTTGTTCTACTCCCT-3′
β-actin_F 5′-GGCTGTATTCCC CTC CATCG-3′
β-actin_R 5′-CCAGTTGGTAACAATGCCATGT-3′
appeared restricted to medium spiny neurons that are known
to express Camk2a (Figure 2B). In addition, analysis of the
amygdala revealed sparse EGFP-L10a expression in the basal sub-
division, presumably in projection neurons known to express
Camk2a (Figure 2C). The lack of EGFP-L10a expression in other
types of neurons known to express Camk2a is due to a more
restricted expression of tTA, presumably due to the genomic
integration site of the Camk2a-tTA transgene (Mayford et al.,
1996). Expression of EGFP-L10a in Camk2a-TRAP mice was tTA-
dependent, as single transgenic tetO-TRAP mice did not express
any EGFP-L10a in the brain (data not shown). In order to con-
ﬁrm the cell-type speciﬁcity of EGFP-L10a expression in the
Camk2a-TRAP mice, we performed immunostaining for Gad1,
a marker of inhibitory interneurons, as well as Gfap, an astro-
cyte marker. No overlap of EGFP-L10a with either Gad1 or Gfap
was seen in the CA1, conﬁrming that the transgene was not
expressed in CA1 interneurons or astrocytes (Figures 2D–G).
Compared with our recent study (Ainsley et al., 2014), the expres-
sion data in Figures 1 and 2 extend the analysis of EGFP-L10a
expression patterns in Camk2a-TRAP mice by providing more
detail for a larger number of brain regions. In summary, the
expression data from Camk2a-TRAP mice conﬁrm cell-type
speciﬁc tTA-dependent expression of EGFP-L10a, thereby val-
idating proper transgene functioning in the tetO-TRAP mouse
line.
COLLECTION OF RIBOSOME-BOUND mRNA FROM CA1 PYRAMIDAL
NEURONS IN THE Camk2a-TRAP MOUSE
To ensure that the EGFP-L10a expressed by Camk2a-TRAP mice
integrates into ribosomal complexes, we performed a Co-IP of
EGFP-L10a, and probed for a member of the small ribosomal
subunit, RPS6. Co-IP of RPS6 would indicate that EGFP-L10a
had successfully integrated into the large ribosomal complex,
and that this large ribosomal complex was subsequently able
to associate with the small ribosomal complex to form a com-
plete ribosome. Immunoprecipitation of EGFP-L10a from whole
brain lysate resulted in the Co-IP of RPS6, indicating functional
integration of EGFP-L10a into whole ribosomes (Figure 3A).
RPS6 was not Co-IPed when using a single transgenic animal
that did not express EGFP-L10a, conﬁrming the speciﬁcity of the
Co-IP.
The immunohistochemical analysis of Camk2a-TRAP mice
revealed that EGFP-L10a is expressed in excitatory pyramidal
cells of the CA1, but not in interneurons or astrocytes in the
CA1 or in other subregions of the hippocampus (Figure 2).
To determine if this expression pattern enabled the collection
of cell-type speciﬁc mRNA from CA1 pyramidal neurons, we
attempted to collect ribosome-bound mRNA from whole hip-
pocampal lysate of Camk2a-TRAP mice. In a previous study
we found that neuronal activation increased the association of
mRNA with ribosomes (Ainsley et al., 2014), in agreement with
previous reports (Weiler and Greenough, 1991, 1993; Job and
Eberwine, 2001; Niere et al., 2012; Buxbaum et al., 2014). We
therefore subjected all of our animals to a 500 s long contextual
FC trial before tissue collection. The quality of the ribosome-
bound mRNA isolated from Camk2a-TRAP mice was analyzed
using an RNA Bioanalyzer. FC single transgenic Camk2a-tTA ani-
mals subjected to the TRAP IP were used as negative controls.
Bioanalyzer analysis of Camk2a-TRAP RNA samples revealed
the presence of high-quality RNA as indicated by a high RNA
integrity number (RIN). The RIN value is calculated based on the
entire electrophoretic trace of the RNA sample, and takes into
account the quantity of RNA degradation (Mueller et al., 2004).
No RNA was detected in TRAP IP samples from single trans-
genic mice, conﬁrming the speciﬁcity of our TRAP IP protocol
(Figure 3B). The Camk2a-TRAP RNA sample contained both
rRNA and mRNA. This conﬁrmed that the TRAP IP collected
ribosomes (which contain rRNA) bound to mRNA, in agreement
with the incorporation of EGFP-L10a into functional translating
ribosomes.
Within the hippocampus, EGFP-L10a is only expressed in CA1
pyramidal neurons, so we expected to see an enrichment of tran-
scripts expressed in CA1 pyramidal neurons in the TRAP IP
samples, as well as a depletion of genes expressed completely or
predominantly outside of CA1 pyramidal neurons. We therefore
performed a qPCR analysis of two genes not expressed in CA1
pyramidal neurons (Gad1 andGfap), one gene expressed predom-
inantly outside of CA1 pyramidal neurons (Pkia), and two genes
that are widely expressed in CA1 pyramidal neurons (Camk2a and
Naa38; Figure 3C; Lein et al., 2007). ct values were calculated
using β-actin as a reference gene. Only the two genes known to
be widely expressed in CA1 pyramidal neurons were enriched in
the IP samples, while the other genes showed a marked depletion
(Figure 3D). In summary, our data show that Camk2a-TRAPmice
enable the cell-type speciﬁc collection of ribosome-bound mRNA
from CA1 pyramidal neurons.
CREATION OF AN ACTIVITY-INDUCED EGFP-L10a MOUSE LINE
After validation of the Camk2a-TRAP mouse line, we used the
tetO-TRAP mouse to create a second TRAP mouse model that
enables the activity-induced expression of EGFP-L10a. For this
purpose, we crossed the tetO-TRAP mouse line with a Fos-tTA
mouse to drive expression of EGFP-L10a under control of the
activity-regulated Fos promoter (Fos-TRAP mouse). Fos is an
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FIGURE 3 | Cell-type specific collection of ribosome-bound mRNA using
the Camk2a-TRAP mouse. (A) Representative afﬁnity puriﬁcation of
EGFP-L10a and co-immunoprecipitation of the small ribosomal protein RPS6
from whole brain lysate of Camk2a-TRAP animals (N = 6), and wild type
littermate controls (WT; N = 6). 2.5% of sample was used for input prior to
the IP. EGFP-L10a is only visible in the IP lane of the Camk2a-TRAP mice
because the IP samples were highly concentrated compared to the input
lanes. No RPS6 was co-puriﬁed from wild type samples that did not contain
EGFP-L10a. The IgG control lane conﬁrms the absence of IgG contamination
artifacts. (B) Representative bioanalyzer plot of RNA samples from
Camk2a-TRAP (blue; RIN mean ± SEM, 7.48 ± 0.14, N = 7) and single
transgenic littermates (red; RIN mean ± SEM, 2.2 ± 1.2, N = 3) indicating
successful isolation of ribosome-bound RNA from Camk2a-TRAP mice, but
not single transgenic controls. mRNA is represented by the area under the
curve between 200 and 4000 nt, with the 18S and 28S peaks representing
rRNA present in the afﬁnity puriﬁed ribosomes. The peaks between 25 and
200 nt represent small rRNAs and tRNAs, as well as highly degraded mRNA
typically seen with Trizol extraction protocols. (C) In situ hybridization images
from the Allan Brain Atlas showing localization of genes used for qPCR
analysis. Two negative control genes (Gad1 and Gfap) are not expressed in
CA1 pyramidal neurons, and one negative control gene (Pkia) is mainly
expressed outside of CA1 pyramidal neurons. Positive control genes
(Camk2a and Naa38) are widely expressed in CA1 pyramidal neurons.
Beta-actin is expressed in all cell-types throughout the hippocampus and was
therefore used as a housekeeping gene for ct analysis. Scale bars,
0.42 mm. (D) qPCR analysis of mRNA collected with the TRAP protocol from
Camk2a-TRAP animals. Negative control genes (Gad1, Pkia, and Gfap) all
showed a signiﬁcant depletion from the IP samples, while positive control
genes (Camk2a and Naa38) both showed signiﬁcant enrichment in the IP
samples. (One tailed t -test with mu = 0. *P < 0.05, ***P < 0.001; Gad1
P = 0.046, Pkia P = 0.045, Gfap P = 0.016, Camk2a P = 0.0005, Naa38
P = 0.001). N = 3.
immediate early gene (IEG) whose promoter is rapidly activated
upon neuronal stimulation (Flavell andGreenberg, 2008). Accord-
ingly, the Fos-tTA mouse can trigger expression of tetO-regulated
reporter proteins in activated neurons, including activated CA1
pyramidal neurons (Reijmers et al., 2007; Matsuo et al., 2008;
Tayler et al., 2013). The Fos-tTAmouse is also referred to as theTet-
Tag mouse, which stands for “Tet”racycline controlled “Tag”ging.
The time-window during which tagging of activated neurons
occurs is opened by the removal of dox from the food, after which
Fos-promoter driven tTA can bind to the tetOpromoter. The time-
window is closed by adding dox back to the food, after which dox
prevents binding of tTA to the tetO promoter (Figure 5A).
Successful mRNA isolation by TRAP requires high expression
levels of EGFP-L10a, since this fusion protein has to out-compete
endogenous L10a for its incorporation into ribosomes. However,
the Fos promoter is activated for only a short period of time after
neuronal activation. We were concerned that the brief period of
Fos promoter activation would not drive sufﬁcient EGFP-L10a
expression for successful mRNA isolation using the TRAP tech-
nique. A previous study characterizing tetO-driven transgene
expression found that mice bred and raised in the absence of
dox later showed higher expression levels of the transgene when
compared to mice bred and raised in the presence of dox (Bejar
et al., 2002). One explanation for this phenomenon is that the
expression of the tetO-driven transgene during brain develop-
ment might prevent its epigenetic silencing. To prevent potential
epigenetic silencing, we bred and raised Fos-TRAP mice in the
absence of dox, put the mice on food with dox after weaning, and
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FIGURE 4 | Complete degradation of developmentally expressed
EGFP-L10a requires 6 weeks. (A) Schematic representation of dox
control over EGFP-L10a expression in the Camk2a-TRAP mouse model.
In the absence of dox, tTA is able to bind to the tetO promoter and
drive EGFP-L10a expression. In the presence of dox, tTA is no longer
able to activate the tetO promoter, thereby preventing any further
expression of EGFP-L10a. (B) Experimental design showing the
time-points of brain dissection after adding dox, and the anticipated
level of EGFP-L10a protein. (C) Images of the CA1 region of the
hippocampus show that depletion of high levels of EGFP-L10a takes
6 weeks of continuous dox. Scale bar, 100 μm. N = 1 for each
time-point.
then waited until all the developmentally expressed EGFP-L10a
was degraded. For this, we ﬁrst needed to determine for how long
Fos-TRAPmice had to be kept on foodwith dox in order to achieve
complete degradation of EGFP-L10a. We found that a period of
6 weeks of dox following high developmental EGFP-L10a expres-
sion can be sufﬁcient for the complete degradation of EGFP-L10a
(Figures 4A–C).
To determine if the Fos-TRAP mouse line can be used for the
activity-induced expression of EGFP-L10a, we compared EGFP-
L10a expression in HC animals versus animals that underwent a
FC trial. Fos-TRAP mice were bred and raised without dox to pre-
vent potential epigenetic silencing, and were kept on dox for at
least 6 weeks following weaning to allow complete degradation of
all developmentally expressed EGFP-L10a. We removed dox from
the diet of both FC and HC animals on day-3 of the experiment,
and subjected the FC group to FC on day 0 (Figures 5A,B). At
the end of day 0, both HC and FC mice were put back on dox,
and brains were dissected on day 3. Comparison of the HC and
FC animals revealed a signiﬁcant increase in the number of EGFP-
L10a expressing cells in the CA1 of the hippocampus of the FC
group as compared with the HC group (Figures 5C–E), in agree-
ment with an earlier study that used Fos-tTA × tetO-histoneGFP
mice (Tayler et al., 2013). Therefore, the increased neuronal activa-
tion in the CA1 caused by FC resulted in the predicted increase in
EGFP-L10a expression. In addition, analysis of cell-type speciﬁcity
of EGFP-L10a expression found no overlap of EGFP-L10awith the
interneuronmarker Gad1, revealing that EGFP-L10a expression in
the CA1 is speciﬁc to pyramidal neurons (Figures 5F–I). The Fos-
TRAPmouse can therefore be used to drive EGFP-L10a expression
in CA1 pyramidal neurons that are activated during a behavioral
test.
DISCUSSION
In order to expand the arsenal of TRAP-based tools for isolating
ribosome-bound mRNA from deﬁned cell types, we have gener-
ated a novel mouse line in which EGFP-L10a expression is under
the control of the tetO promoter. We crossed this line with two
different transgenic tTA mice, one driving tTA under the control
of the Camk2a promoter, and one driving tTA under control of
the Fos promoter to create Camk2a-TRAP and Fos-TRAP mice,
respectively. We found that in both lines EGFP-L10a exhibited
expression patterns similar to other tetO-driven genes that have
previously been crossed into Camk2a-tTA and Fos-tTA driver
mice. Using the Camk2a-TRAP mice we showed that tetO-driven
EGFP-L10a integrates into functional ribosomes, and that high
quality cell-type speciﬁc mRNA can be collected through afﬁnity
puriﬁcation of the EGFP-L10a tagged ribosomes.
By using the tTA system we enabled both spatial and tempo-
ral control over EGFP-L10a expression. The ability to cross the
tetO-TRAP mouse line with various cell-type speciﬁc tTA driver
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FIGURE 5 | Creation and characterization of the Fos-TRAP mouse line.
(A) Schematic of the Fos-TRAP mouse model. Activation of the activity
induced Fos promoter induces tTA transcription. When present, dox binds
to tTA and prevents it from interacting with the tetO promoter. Removal of
dox enables tTA to bind to the tetO promoter and drive expression of
EGFP-L10a. (B) Experimental design. Mice were given dox chow for
8–10 weeks after weaning to enable complete degradation of
developmentally expressed EGFP-L10a. On day-3, dox was removed from
the diet. FC was done in the absence of dox on day 0 to allow EGFP-L10a
expression in activated neurons. Following FC, all animals were put back on
dox to prevent further EGFP-L10a transcription. Brains were collected on
day 3 to allow time for EGFP-L10a protein accumulation. (C,D) EGFP-L10a
expression in pyramidal cells of the CA1 region of the hippocampus in (C)
home cage (HC, N = 2) Fos-TRAP mice, and (D) fear conditioned (FC,
N = 3) Fos-TRAP mice. Scale bars, 50 μm. (E) Quantiﬁcation of EGFP-L10a
positive cells per area of CA1 in HC (N = 2) and FC (N = 3) mice. All
values were normalized to a HC group average of 1. **P < 0.01. Two tailed
t -test P = 0.0049. (F–I) EGFP-L10a expression in the CA1 of Fos-TRAP
mice was restricted to pyramidal cells. Mice were bred and raised off dox
to allow for maximal EGFP-L10a expression. No overlap of EGFP-L10a was
observed with the interneuron marker Gad1, marked by the ﬁlled in arrow
(H). Scale bars, 10 μm. (F) Dapi, (G) EGFP-L10a, (H) Gad1, (I) merge.
lines, such as the Camk2a-tTA line, confers spatial control by
restricting EGFP-L10a expression to these cell-types. Though a
number of BAC transgenic TRAPmice have been generated for the
targeting of various cell-types in the brain (Doyle et al., 2008), our
tetO-TRAP mouse signiﬁcantly expands the number of cell types
that are now amendable to TRAP analysis. The ability to manip-
ulate the timing of EGFP-L10a expression through the use of dox
in the food confers temporal control. Temporal control allows the
use of activity-induced promoters such as the Fos promoter to tag
cells that are activated during a speciﬁc time window, for example
when a behavioral task is executed. In addition, temporal control
enables more speciﬁc expression patterns when using promoters
that drive differential expression patterns during different phases
of development.
In this paper, we report how the Camk2a-TRAP mouse can be
used to collect ribosome-bound mRNA from complete CA1 pyra-
midal neurons by using a straightforward protocol during which
the whole hippocampus is dissected, homogenized, and subjected
to TRAP IP. By using this protocol, we were able to collect high
quality, ribosome-bound mRNA from CA1 pyramidal neurons at
a deﬁned time-point immediately following behavioral activation.
In addition to this whole hippocampal dissection protocol, we
reported in a previous paper that the Camk2a-TRAP mouse can
be used to collect ribosome-bound mRNA from in vivo dendrites
of CA1 pyramidal neurons by using a more speciﬁc dissection
protocol (Ainsley et al., 2014). To the best of our knowledge, the
Camk2a-TRAPmouse is the ﬁrst reportedmouse line that enables
the collection of ribosome-bound mRNA from CA1 pyramidal
neurons. Given the important role of CA1 pyramidal neurons in
learning and memory, we anticipate that future studies will use
the Camk2a-TRAP mouse to discover and characterize molecular
mechanisms of cognition.
The Fos-TRAPmouse is the ﬁrst mousemodel designed for the
collection of ribosome-bound mRNA speciﬁcally from neurons
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that are activated during a behavioral test. Thereby, the Fos-TRAP
mouse should make it possible to study protein synthesis in neu-
rons that are functionally deﬁned. Though our initial data support
the feasibility of using the Fos-TRAP mouse for these purposes,
two caveats need to be addressed in future studies. First, themRNA
isolation experiment reported in this paper was done using the
Camk2a-TRAP mouse line, which expresses high EGFP-L10a lev-
els throughout its lifetime. Because of the inducible nature of the
Fos-TRAPmouse line, EGFP-L10a is only expressed during a short
time window. It remains to be determined whether the resulting
EGFP-L10a expression levels will produce a sufﬁcient number of
EGFP-tagged ribosomes to enable successful afﬁnity puriﬁcation.
Second, after translation, EGFP-L10a must integrate into func-
tional ribosomes in order for the TRAP IP protocol to be effective.
Therefore, sufﬁcient timemust be allowed after Fos promoter acti-
vation for EGFP-L10a translation and ribosome integration. At
this point, it is unknown how long it takes for a newly synthesized
EGFP-L10a protein to be incorporated into a functional ribosome.
Though these caveats need to be addressed in future studies, our
current data provide an important ﬁrst validation by showing that
EGFP-L10a levels in CA1 pyramidal neurons of Fos-TRAP mice
increase after FC. In addition, the creation of the Fos-TRAPmouse
line afﬁrms the versatility of the tetO-TRAP mouse by showing
that it can be crossed with different tTA drivers to enable a variety
of EGFP-L10a expression patterns.
In summary, we developed a tetO-TRAP mouse line for
expressing EGFP-L10a with high spatial and temporal control,
thereby expanding the collection of available TRAP mouse lines.
Compared with other methods for collecting cell-type speciﬁc
mRNA, the TRAP technique is more efﬁcient than LCM andman-
ual cell sorting, causes less gene expression artifacts than FACS
and other cell sorting methods that require dissociation of cells
from tissue, and collects translated mRNA instead of total mRNA.
We have demonstrated that the tetO-TRAP mouse can be crossed
with both the Camk2a-tTA and Fos-tTA driver lines to produce
cell-type speciﬁc EGFP-L10a expression, and that it can be used for
collecting ribosome-bound mRNA from CA1 pyramidal neurons.
Although our analyses were focused on CA1 pyramidal neurons,
we anticipate that the tetO-TRAP mouse can be used for a large
variety of translational proﬁling purposes, both within the brain
and in peripheral tissues, by crossing the tetO-TRAP mouse with
other tTA driver mice (Schonig et al., 2010).
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